SuperworthLexeo Therapeutics market cap LXEO
Share price times shares outstanding: what the whole company sells for, since 2023.
- Today, Oct 23, 2026
- $229.7M
- Highest close in our data
- $769.3M
- Jan 2026
Lexeo Therapeutics is worth $229.7M at the close on Oct 23, 2026, at $2.80 a share.
That is down 54% over the last year.
Its highest close in our data was $769.3M in Jan 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $229.7M | $216.6M | $769.3M | −69% |
| 2025 | $748.1M | $65.7M | $755.4M | +234% |
| 2024 | $224.2M | $207.7M | $579.8M | −37% |
| 2023 | $357.6M | $333.3M | $414.3M | n/a |
Against its peers
Companies in Biotechnology nearest Lexeo Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| LXEOLexeo Therapeutics | $229.7M |
| PLXProtalix BioTherapeutics | $205.5M |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| Peer median | $884.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Lexeo Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.